Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Yang qi deficiency syndrome correction" refers to the TCM practice of correcting a symptom complex (“syndrome”) characterized by low Yang qi—where ‘Yang’ is the warming, activating aspect of vital energy and ‘Qi’ is circulating life-force. Clinically, Yang qi deficiency manifests as cold intolerance, fatigue, hypoactivity of metabolism, immune weakness, and circulatory problems. Corrections are performed through administration of herbal therapies, lifestyle modifications, acupuncture, and dietary changes, all aiming to restore metabolic balance and warm the body[1][2][3][7]. In some biomedical research mapping, the syndrome is associated with mitochondrial dysfunction or energy metabolism disorders, but it is not the name of a molecular entity or drug target[1][3][6]. Various TCM herbs, such as Cistanches Herba and Schisandrae Fructus, are used to “invigorate” Yang and Qi, believed to benefit conditions like chronic fatigue syndrome with symptoms resembling mitochondrial dysfunction[6]. This term describes a therapeutic intervention or syndrome, not a molecule, protein, receptor, enzyme, or other druggable target. Therefore, the canonical_name, abbreviation, molecular classification, and receptor/family designation are not applicable.
This intervention aims to enhance mitochondrial function and improve cellular and systemic energy metabolism.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yang qi deficiency syndrome correction.